These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11457925)

  • 1. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.
    Haila S; Hästbacka J; Böhling T; Karjalainen-Lindsberg ML; Kere J; Saarialho-Kere U
    J Histochem Cytochem; 2001 Aug; 49(8):973-82. PubMed ID: 11457925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
    Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
    Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.
    Rossi A; van der Harten HJ; Beemer FA; Kleijer WJ; Gitzelmann R; Steinmann B; Superti-Furga A
    Hum Genet; 1996 Dec; 98(6):657-61. PubMed ID: 8931695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.
    Karniski LP
    Hum Mol Genet; 2004 Oct; 13(19):2165-71. PubMed ID: 15294877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.
    Forlino A; Piazza R; Tiveron C; Della Torre S; Tatangelo L; Bonafè L; Gualeni B; Romano A; Pecora F; Superti-Furga A; Cetta G; Rossi A
    Hum Mol Genet; 2005 Mar; 14(6):859-71. PubMed ID: 15703192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from a transgenic mouse model on the role of SLC26A2 in health and disease.
    Forlino A; Gualeni B; Pecora F; Della Torre S; Piazza R; Tiveron C; Tatangelo L; Superti-Furga A; Cetta G; Rossi A
    Novartis Found Symp; 2006; 273():193-206; discussion 206-12, 261-4. PubMed ID: 17120769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia.
    Bonafé L; Hästbacka J; de la Chapelle A; Campos-Xavier AB; Chiesa C; Forlino A; Superti-Furga A; Rossi A
    J Med Genet; 2008 Dec; 45(12):827-31. PubMed ID: 18708426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.
    Rossi A; Superti-Furga A
    Hum Mutat; 2001 Mar; 17(3):159-71. PubMed ID: 11241838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
    Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
    Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
    Karniski LP
    Hum Mol Genet; 2001 Jul; 10(14):1485-90. PubMed ID: 11448940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
    Rossi A; Bonaventure J; Delezoide AL; Superti-Furga A; Cetta G
    Eur J Biochem; 1997 Sep; 248(3):741-7. PubMed ID: 9342225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations.
    Superti-Furga A; Rossi A; Steinmann B; Gitzelmann R
    Am J Med Genet; 1996 May; 63(1):144-7. PubMed ID: 8723100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family.
    Dwyer E; Hyland J; Modaff P; Pauli RM
    Am J Med Genet A; 2010 Dec; 152A(12):3043-50. PubMed ID: 21077202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
    Hästbacka J; Superti-Furga A; Wilcox WR; Rimoin DL; Cohn DH; Lander ES
    Am J Hum Genet; 1996 Feb; 58(2):255-62. PubMed ID: 8571951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compound heterozygote SLC26A2 mutation resulting in robin sequence, mild limbs shortness, accelerated carpal ossification, and multiple epiphysial dysplasia in two Brazilian sisters. A new intermediate phenotype between diastrophic dysplasia and recessive multiple epiphyseal dysplasia.
    Zechi-Ceide RM; Moura PP; Raskin S; Richieri-Costa A; Guion-Almeida ML
    Am J Med Genet A; 2013 Aug; 161A(8):2088-94. PubMed ID: 23840040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.
    Satoh H; Susaki M; Shukunami C; Iyama K; Negoro T; Hiraki Y
    J Biol Chem; 1998 May; 273(20):12307-15. PubMed ID: 9575183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.
    Superti-Furga A; Hästbacka J; Wilcox WR; Cohn DH; van der Harten HJ; Rossi A; Blau N; Rimoin DL; Steinmann B; Lander ES; Gitzelmann R
    Nat Genet; 1996 Jan; 12(1):100-2. PubMed ID: 8528239
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenetics of the human SLC26 transporters.
    Dawson PA; Markovich D
    Curr Med Chem; 2005; 12(4):385-96. PubMed ID: 15720248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.
    Rossi A; Bonaventure J; Delezoide AL; Cetta G; Superti-Furga A
    J Biol Chem; 1996 Aug; 271(31):18456-64. PubMed ID: 8702490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia.
    Miyake A; Nishimura G; Futami T; Ohashi H; Chiba K; Toyama Y; Furuichi T; Ikegawa S
    J Hum Genet; 2008; 53(8):764-768. PubMed ID: 18553123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.